These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer. Petraki C; Dubinski W; Scorilas A; Saleh C; Pasic MD; Komborozos V; Khalil B; Gabril MY; Streutker C; Diamandis EP; Yousef GM Pathol Res Pract; 2012 Feb; 208(2):104-8. PubMed ID: 22285222 [TBL] [Abstract][Full Text] [Related]
3. Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancer. Talieri M; Alexopoulou DK; Scorilas A; Kypraios D; Arnogiannaki N; Devetzi M; Patsavela M; Xynopoulos D Tumour Biol; 2011 Aug; 32(4):737-44. PubMed ID: 21487810 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of kallikrein gene 10 is a biomarker for predicting poor prognosis in gastric cancer. Jiao X; Lu HJ; Zhai MM; Tan ZJ; Zhi HN; Liu XM; Liu CH; Zhang DP World J Gastroenterol; 2013 Dec; 19(48):9425-31. PubMed ID: 24409072 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer. Alexopoulou DK; Papadopoulos IN; Scorilas A Clin Biochem; 2013 Oct; 46(15):1453-61. PubMed ID: 23499583 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer. Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of human tissue kallikrein-related peptidases 6 and 10 in gastric cancer. Kolin DL; Sy K; Rotondo F; Bassily MN; Kovacs K; Brezden-Masley C; Streutker CJ; Yousef GM Biol Chem; 2014 Sep; 395(9):1087-93. PubMed ID: 25153389 [TBL] [Abstract][Full Text] [Related]
8. A retrospective cohort study of clinical value of PRL-3 in stage III human colorectal cancer. Liu C; Zhong W; Xia L; Fang C; Liu H; Liu X Medicine (Baltimore); 2021 Apr; 100(17):e25658. PubMed ID: 33907129 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma. Grin A; Samaan S; Tripathi M; Rotondo F; Kovacs K; Bassily MN; Yousef GM Hum Pathol; 2015 Apr; 46(4):541-8. PubMed ID: 25649006 [TBL] [Abstract][Full Text] [Related]
10. Kallikrein-related peptidase 10 predicts prognosis and mediates tumor immunomodulation in colorectal cancer. Luo YC; Lv YL; He RX; Shi XX; Jiang T Biochem Biophys Res Commun; 2023 Dec; 689():149217. PubMed ID: 37972446 [TBL] [Abstract][Full Text] [Related]
11. Serum carboxypeptidaseA4 levels predict liver metastasis in colorectal carcinoma. Sun L; Guo C; Burnett J; Yang Z; Ran Y; Sun D Oncotarget; 2016 Nov; 7(48):78688-78697. PubMed ID: 27780921 [TBL] [Abstract][Full Text] [Related]
12. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer]. Wu F; Chen L; Wu W; Jiang B; Su X Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527 [TBL] [Abstract][Full Text] [Related]
13. Kallikrein-related peptidase 10 (KLK10) expression and single nucleotide polymorphisms in ovarian cancer survival. Batra J; Tan OL; O'Mara T; Zammit R; Nagle CM; Clements JA; Kedda MA; Spurdle AB Int J Gynecol Cancer; 2010 May; 20(4):529-36. PubMed ID: 20686372 [TBL] [Abstract][Full Text] [Related]
14. Kallikrein 10 (KLK10) methylation as a novel prognostic biomarker in early breast cancer. Kioulafa M; Kaklamanis L; Stathopoulos E; Mavroudis D; Georgoulias V; Lianidou ES Ann Oncol; 2009 Jun; 20(6):1020-5. PubMed ID: 19150938 [TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival. Michaelidou K; Ardavanis A; Scorilas A Breast Cancer Res Treat; 2015 Jul; 152(2):323-36. PubMed ID: 26099606 [TBL] [Abstract][Full Text] [Related]
16. Twist2 is a valuable prognostic biomarker for colorectal cancer. Yu H; Jin GZ; Liu K; Dong H; Yu H; Duan JC; Li Z; Dong W; Cong WM; Yang JH World J Gastroenterol; 2013 Apr; 19(15):2404-11. PubMed ID: 23613636 [TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer. Gong W; Liu Y; Seidl C; Diamandis EP; Kiechle M; Drecoll E; Kotzsch M; Magdolen V; Dorn J BMC Cancer; 2019 Jul; 19(1):696. PubMed ID: 31307411 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of β1 integrin expression in colorectal liver metastases. Vassos N; Rau T; Merkel S; Feiersinger F; Geppert CI; Stürzl M; Hohenberger W; Croner RS Int J Clin Exp Pathol; 2014; 7(1):288-300. PubMed ID: 24427350 [TBL] [Abstract][Full Text] [Related]
19. Elevated tumor tissue protein expression levels of kallikrein-related peptidases KLK10 and KLK11 are associated with a better prognosis in advanced high-grade serous ovarian cancer patients. Geng X; Liu Y; Dreyer T; Bronger H; Drecoll E; Magdolen V; Dorn J Am J Cancer Res; 2018; 8(9):1856-1864. PubMed ID: 30323977 [TBL] [Abstract][Full Text] [Related]
20. Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapy. Lee YC; Su CY; Lin YF; Lin CM; Fang CY; Lin YK; Hsiao M; Chen CL Oncotarget; 2017 Feb; 8(7):12120-12132. PubMed ID: 28076332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]